Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study
Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study
复制标题
DOI:
10.1093/cid/cix1086
复制
发表时间:
2018-06-01
影响因子:
11.8
通讯作者:
Holtz, Timothy H.
中科院分区:
文献类型:
--
作者:
Grant, Robert M.;Mannheimer, Sharon;Holtz, Timothy H.
Background. Nondaily dosing of oral preexposure prophylaxis (PrEP) may provide equivalent coverage of sex events compared with daily dosing.Methods. At-risk men and transgender women who have sex with men were randomly assigned to 1 of 3 dosing regimens: 1 tablet daily, 1 tablet twice weekly with a postsex dose (time-driven), or 1 tablet before and after sex (event-driven), and were followed for coverage of sex events with pre- and postsex dosing measured by weekly self-report, drug concentrations, and electronic drug monitoring.Results. From July 2012 to May 2014, 357 participants were randomized. In Bangkok, the coverage of sex events was 85% for the daily arm compared with 84% for the time-driven arm (P=.79) and 74% for the event-driven arm (P=.02). In Harlem, coverage was 66%, 47% (P=.01), and 52% (P=.01) for these groups. In Bangkok, PrEP medication concentrations in blood were consistent with use of >= 2 tablets per week in > 95% of visits when sex was reported in the prior week, while in Harlem, such medication concentrations occurred in 48.5% in the daily arm, 30.9% in the time-driven arm, and 16.7% in the event-driven arm (P